
MHC I Monomers and Tetramers

Major histocompatibility complex (MHC) class I molecules are glycoproteins found on the surfaces of almost all nucleated cells. Their major function is to present peptide antigens that originate inside the cell, e.g., viral proteins, to cytotoxic T cells (CD8). Presented antigens are then monitored by CD8 cells as part of a surveillance system that destroys cells bearing pathogenic or foreign peptide antigens, such as malignant or virus-infected cells.
MHC I molecules also bind peptides derived from vaccines, biologics and cancer neo-epitopes, leading to priming of the immune system to either fight the cancer or pathogen or degrade the biologic. One of the keys to success or failure of a new biotherapeutic lies in how the immune system of the patient reacts to the drug. Understanding how MHC molecules recognise and bind epitopes can help drug developers to find the “right” immune-stimulating properties early during development i.e. where the immune system is mobilised to fight the disease without neutralising the drug’s effect, e.g., through the development of neutralising antibodies (NAb).
Broad Portfolio of MHC I Alleles and MHC/Peptide Complexes
Immunitrack has a broad portfolio of MHC alleles, including: 65 Human MHC I alleles (subtypes HLA-A, HLA-B, HLA-C), 5 Murine MHC I alleles (MLA) and 1 canine MHC I allele (DLA).
We can produce and deliver custom complexes based on the MHC alleles we have in our repository or based on other alleles that you wish to request. MHC/peptide binding assays will initially be performed to test whether or not we can produce the desired complexes since prediction tools are not always reliable.
MHC I monomers are biotinylated and can be complexed with the labelled streptavidin of your choice. MHC I tetramers are labelled with phycoerythrin (PE) or allophycocyanin (APC), and are ready for use in flow cytometry.
Applications
- Tetramer staining. MHC-peptide tetramers are used to detect antigen-specifc T cells in T cell mixtures using flow cytometry.
- Multimer production. Our monomers are compatible with dextramer, tetramer, pentamer and other multimer technologies.
- T cell stimulation. MHC I molecules in complex with peptide epitopes can be used to stimulate CD8 T cells for flow cytometry experiments.
- Generation of T cell receptor-like antibodies. Peptide/MHC (pMHC) complexes can be used with phage display technology to generate libraries of specific T cell receptor-like antibodies for use in research, diagnosis, and immunotherapy.
- Isolating T cells for T cell receptor-based therapy including CAR-T. Peptide/MHC (pMHC) complexes can be used to isolate and sequence T cell receptors for use in research, diagnosis, and immunotherapy.
Product Information
- Storage Buffer: PBS, 50% glycerol.
- Concentration: 0.5 mg/mL. Determined by absorbance at 280 nm and Coomassie staining.
- Sizes Available: 50, 100, 150, 200, 250, 300, 350, 400 and 450 μg supplied as individual vials containing 100 μL product.
- Sizes Available – custom orders: We can accommodate most requests concerning product size. For A0201, we may produce up to mg quantities.
- Stabilisers: 1 % BSA.
- Storage: Store vial at -20° C prior to opening. Dilute only prior to immediate use.
- Expiration: 6 months from date of opening.
Delivery Information
All products are shipped preservative-free in liquid form at 0 °C.
Application Notes
In this application note tetramers for Flu, CMV and Mart1 are tested by flow cytometry on PBMC from blood donors. Download ▸
Protocol for tetramer staining using our tetramers. Download ▸
Supporting Data for MHC Class I Monomers and Tetramers
Our biotinylated MHC I complexes have been used as tetramer reagents as well as for the stimulation of CD8 T cells in several publications. In the example shown below, two tetramers B*0801-IE188-96 and B*0801-IE199-207 were used in flow cytometry experiments to validate CD8 T cell responses against human cytomegalovirus (HCMV) protein IE1.
Source: Adapted from: PlosOne April 2014, Volume 9,Issue 4,e94892 Identification and HLA-Tetramer-Validation of Human CD4+ and CD8+ T Cell Responses against HCMV Proteins IE1 and IE2.
Key Publications
- Fadel, T.R. et al. A carbon nanotube-polymer composite for T-cell therapy. Nat Nanotechnol. 2014 9(8):639-47.
- Braendstrup, P. et al. Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2. PLoS One. 2014. 9(4):e94892.
Ordering
To inquire about an order, you can either use our contact form or send a mail to info@immunitrack.com. Remember to submit also your contact details. We will contact you back within 24 hours with additional questions before providing a quote.
Custom MHC Reagents
We offer a market-leading turnaround time of 3-5 weeks on custom orders of MHC/peptide complexes. You are welcome to submit your request by sending us a list of MHC alleles and peptides you wish to apply either for custom reagent production or NeoScreen assessment. On the MHC Allele Library page you find a complete list of our MHC alleles.
Tel. +45 28682159